Searched for
INDIAN IMMUNOLOGICALS LIMITED
Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...- For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
- Biocon rolls out two biosimilars in US marketBiocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...
- Abhayrab rabies vaccine: IIL says counterfeit batch no longer availableIndian Immunologicals Limited clarifies a packaging anomaly in one batch of its anti-rabies vaccine, Abhayrab. The company states that coun...
- Indian Immunologicals targets dengue vaccine launch by January 2026Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top execu...
- PSU vaccine maker IIL to invest Rs 700 crore on new facility in HyderabadThe proposed facility will be making Foot and Mouth disease (FMD) and other emerging diseases. The facility will create total employment fo...
- IIL to make 10 million doses of Covaxin drug substance from DecemberIndian Immunologicals' Managing Director K Anand Kumar informed that IIL is also working on an attenuated COVID-19 vaccine which is likely ...
- Covaxin single-dose for survivor may be as effective as both for uninfectedAccording to a pilot study by ICMR (Indian Council for Medical Research) a single dose of Bharat Biotech’s Covaxin in people who have been ...
- Monthly production capacity of Covishield, Covaxin planned to be increased: GovtFrom January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by B...
- IIL may start supplying 20 lakh doses of Covaxin by September: GovtOn the production plan of Covaxin at various facilities, NITI Aayog member (Health) Dr V K Paul said there were some initial hiccups relate...
- Monthly production capacity of Covishield projected to increase to 120 million doses, Covaxin to 58 million doses: MinisterUnion Health Minister Mansukh Mandaviya was responding to a question on the current capacity to manufacture Covaxin and Covishield in the c...
- Only marginal difference in purchase price of Covishield, Covaxin for Centre: MoS HealthIn fact, the Government of India has been supplying vaccines free of cost to the states/UTs for administration to prioritised beneficiaries...
- Government exploring possibility of Covaxin production outside IndiaThe government also intends to take up the matter with the World Health Organisation (WHO) to step up Covaxin production.
- Reports of delay in licensing for Covaxin 'factually incorrect': Govt"There have been reports in a section of the media followed by some uninformed tweets alleging delay in licensing for Covaxin and delayed a...
- Govt aims for 6-7 crore Covaxin doses/month by July-AugustThe state-run Public Sector Undertaking (PSUs) will manufacture the drug on the basis of transfer of technology. “The government of India w...
- COVID-19 vaccine development at early stage in India; breakthrough unlikely within a year: ExpertsReferring to a vaccine to fight the virus, a PMO statement had said that it is the most pressing need and Indian academia, start-ups and in...
- IIL set to expand its protozoan Vaccine portfolioInstituto Nacional de Tecnologia Agropecuaria (INTA) is Argentina’s federal agency in charge of the generation, adaptation and diffusion of...
- NDDB-arm develops world’s first vaccine against tapeworms in pigsIIL has obtained the license the to manufacture and market the vaccine after conducting extensive field trials in India and many other coun...
- IIL opens 'New Bovine Serum' manufacturing unit in New ZealandBiologicals company Indian Immunologicals Limited (IIL) today inaugurated its 'New Bovine Serum' manufacturing plant in New Zealand.
Load More
